Keywords: BZD، بنزودیازپین; BPO, Benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate; BSA, bovine serum albumin; BZD, benzodiazepine; DBU, 1,8-diazabicycloundec-7-ene; DIPEA, N,N-Diisopropylethylamine; DMAD, dimethyl acetylenedicarboxylate; DNA, Deoxyribonucl
مقالات ISI BZD، بنزودیازپین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BZD، بنزودیازپین; Beta-carboline; GABA; Anxiety; EEG; Photosensitivity; Abecarnil; FlumazenilAED, antiepileptic drug; BZD, benzodiazepine; IPS, intermittent photic stimulation; PoC, proof-of-concept; PPR, photo-paroxysmal EEG response; SPR, standardised photoparoxysmal res
The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats
Keywords: BZD، بنزودیازپین; Anxiety; Conflict test; Elevated plus maze test; Conditioned fear stress test; 5-HT1A receptorAP521, (R)-piperonyl-1,2,3, 4-tetrahydro[1]-benzothieno[2,3-c]pyridine-3-carboxamide hydrochloride; BZD, benzodiazepine; GAD, general anxiety disorder; 5-HT, 5-h
Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa)
Keywords: BZD، بنزودیازپین; The translocator protein 18KD; YL-IPA08; Anxiolytic; Antidepressant; NeurosteroidsAllo, allopregnanolone; BZD, Benzodiazepine; CBR, central benzodiazepine receptors; CNS, central nervous system; Cort, Corticosterone; CSF, cerebrospinal fluid; FST, forced
Anxiolytic-like effect of linezolid in experimental mouse models of anxiety
Keywords: BZD، بنزودیازپین; MAO, Monoamine oxidase; EPM, Elevated plus maze; L/D, Light/dark; HB, Hole board; BZD, Benzodiazepine; 5-HT, Serotonin; NE, Nor-epinephrine; KO, Knockout; ANOVA, Analysis of variance; GABA, Gamma-amino butyric acidAnimal models; Anti-anxiety; Linezolid; M
The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs
Keywords: BZD، بنزودیازپین; ADD, Antiepileptic Drug Development; AED, antiepileptic drug; ASP, anticonvulsant screening programme; BZD, benzodiazepine; CLZ, clonazepam; DZP, diazepam; NIH, National Institutes of Health; NINDS, National Institute of Neurological Disorders and Stroke;
Hypnotic effects and binding studies for GABAA and 5-HT2C receptors of traditional medicinal plants used in Asia for insomnia
Keywords: BZD، بنزودیازپین; 5-HT, 5-hydroxytryptamine (serotonin); BZD, benzodiazepine; CMC, carboxymethyl cellulose; CNS, central nervous system; DE, danshen (Salvia miltiorrhiza Bunge) ethanol extract; DPM, disintegrations per minute; DZP, diazepam; GABA, gamma-aminobutyric acid;
Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia
Keywords: BZD، بنزودیازپین; AMB, amobarbital; AMT, amitriptyline; BPD, bromperidol; BVU, bromovalerylurea; BZD, benzodiazepine; CBZ, carbamazepine; CLM, clomipramine; CP, chlorpromazine; CRP, carpipramine; FLV, fluvoxamine; HPD, haloperidol; Li, lithium carbonate; LP, levomepromazin
Galantamine is a novel post-exposure therapeutic against lethal VX challenge
Keywords: BZD، بنزودیازپین; Ach, acetylcholine; AChE, acetylcholinesterase; AChEI, acetylcholinesterase inhibitor; ATR, atropine sulfate; AUC, area under curve; BBB, blood brain barrier; BZD, benzodiazepine; CWA, chemical warfare agents; EEG, electroencephalography; GAL, galantamine
New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications
Keywords: BZD، بنزودیازپین; AMPA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid; AWS, Alcohol withdrawal syndrome; BZD, Benzodiazepine; BrAC, Breath alcohol concentration; CNS, Central nervous system; CIWA-Ar, Clinical Institute Withdrawal Assessment for Alcohol-revised; FDA,
A single point mutation of the GABAA receptor α5-subunit confers fluoxetine sensitivity
Keywords: BZD، بنزودیازپین; Allosteric modulation; Mutagenesis; Chimera; Fluoxetine; GABAA receptorAChBP, acetylcholine binding protein; BZD, benzodiazepine; FLX, fluoxetine hydrochloride; GABA, γ-aminobutyric acid; GABAA, γ-aminobutyric acid type A; LGIC, ligand-gated ion channel;
Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: A randomized crossover comparative study with brotizolam
Keywords: BZD، بنزودیازپین; ADR, adverse drug reaction; ANOVA, analysis of variance; BTM, brotizolam; BZD, benzodiazepine; ICSD, International Classification of Sleep Disorders; NBZD, non-benzodiazepine; PPI, psychophysiological insomnia; PSG, polysomnography; SL, sleep latency; SLT